Health Care

90 Seconds With Spark – Recce Pharmaceuticals (ASX:RCE)

In this quick-fire style interview with the Executive Director, Michele Dilizia, Spark Plus discusses about the company, recent positive results for RECCE 327 in MRSA Burns Wound Infection, as well as the investors’ reception about the company.

Published

5 months ago

on

90 Seconds With Spark Interview Between Spark Plus and Michele Dilizia (Executive Director of Recce Pharmaceuticals)

In this quick-fire style interview with the Executive Director, Michele Dilizia, Spark Plus discusses about the company, recent positive results for RECCE 327 in MRSA Burns Wound Infection, as well as the investors’ reception about the company.

Recce Pharmaceuticals is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of antibiotics.

Visit their website for more info: https://www.recce.com.au/

Related Topics:
Click to comment

Trending